Saudi - Delayed Quote SAR

Dallah Healthcare Company (4004.SR)

118.60
-2.00
(-1.66%)
At close: 3:18:27 PM GMT+3
Loading Chart for 4004.SR
  • Previous Close 120.60
  • Open 121.60
  • Bid 119.40 x --
  • Ask 119.40 x --
  • Day's Range 118.60 - 122.00
  • 52 Week Range 113.20 - 170.00
  • Volume 109,475
  • Avg. Volume 111,534
  • Market Cap (intraday) 12.036B
  • Beta (5Y Monthly) 0.12
  • PE Ratio (TTM) 24.61
  • EPS (TTM) 4.82
  • Earnings Date May 14, 2025 - May 16, 2025
  • Forward Dividend & Yield 2.00 (1.66%)
  • Ex-Dividend Date Apr 7, 2025
  • 1y Target Est 147.87

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, and medical polyclinics; and the provision of manpower and support services to hospitals and medical centers. It manufactures and distributes pharmaceutical, herbal and cosmetic products, and toiletries. In addition, the company engages in the management and operation of hospitals owned by third parties. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was incorporated in 1994 and is based in Riyadh, Saudi Arabia.

www.dallahhealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4004.SR

View More

Performance Overview: 4004.SR

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .

YTD Return

4004.SR
20.61%
Tadawul All Shares Index (^TASI.SR)
4.19%

1-Year Return

4004.SR
28.44%
Tadawul All Shares Index (^TASI.SR)
4.86%

3-Year Return

4004.SR
7.92%
Tadawul All Shares Index (^TASI.SR)
10.15%

5-Year Return

4004.SR
232.31%
Tadawul All Shares Index (^TASI.SR)
71.68%

Compare To: 4004.SR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4004.SR

View More

Valuation Measures

Annual
As of 5/13/2025
  • Market Cap

    12.24B

  • Enterprise Value

    13.98B

  • Trailing P/E

    24.97

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.67

  • Price/Book (mrq)

    3.53

  • Enterprise Value/Revenue

    4.36

  • Enterprise Value/EBITDA

    18.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.70%

  • Return on Assets (ttm)

    5.51%

  • Return on Equity (ttm)

    13.44%

  • Revenue (ttm)

    3.21B

  • Net Income Avi to Common (ttm)

    471.2M

  • Diluted EPS (ttm)

    4.82

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    166.32M

  • Total Debt/Equity (mrq)

    53.99%

  • Levered Free Cash Flow (ttm)

    -137.56M

Research Analysis: 4004.SR

View More

Company Insights: 4004.SR

Research Reports: 4004.SR

View More

People Also Watch